Yayın:
Utility of deceased expanded-criteria donors in kidney transplantation: A single-center experience

dc.contributor.authorAyar, Yavuz
dc.contributor.authorSayilar, Emel Isiktas
dc.contributor.authorCan, Fatma Ezgi
dc.contributor.buuauthorERSOY, ALPARSLAN
dc.contributor.buuauthorYILDIZ, ABDULMECİT
dc.contributor.buuauthorORUÇ, AYŞEGÜL
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0342-9692
dc.contributor.researcheridJSL-7718-2023
dc.contributor.researcheridAAH-4002-2021
dc.date.accessioned2025-10-21T09:47:55Z
dc.date.issued2025-05-07
dc.description.abstractPurpose: The success of solid organ transplantation and the consequent increase in the patients on the waiting list has led to an increased utilization of donor kidneys with a high kidney donor profile index (KDPI)/expanded criteria. In our study, patients who underwent transplantation based on the standard and expanded donor criteria were compared in terms of factors affecting graft survival. Data of patients who underwent transplantation from cadavers with standard and extended criteria (SCD, ECD) between 01 July 2011 and 30 June 2016 were evaluated retrospectively. Donor characteristics, treatment type, response and graft characteristics, 1st-, 3rd-, and 5th-year graft survival, and acute rejection rates were analyzed retrospectively. Recent findings: In terms of the causes of death, cerebrovascular accidents were more common in the ECD group (p < 0.001). Hypertension and diabetes were more common in both donor groups and were detected more frequently in recipients in the ECD group (p < 0.001). The absence of mycophenolate mofetil (MMF) use and the presence of an acute rejection attack adversely affected graft survival at the end of the 1st, 3rd, and 5th years. Summary: The utilization of expanded criteria donors is widespread. Appropriate monitoring of patients undergoing immunosuppressive therapy, especially using mycophenolate mofetil (MMF) and the presence of acute rejection, affect graft survival.
dc.identifier.doi10.3390/jcm14093232
dc.identifier.issue9
dc.identifier.scopus2-s2.0-105004882728
dc.identifier.urihttps://doi.org/10.3390/jcm14093232
dc.identifier.urihttps://hdl.handle.net/11452/56196
dc.identifier.volume14
dc.identifier.wos001486770700001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherMdpi
dc.relation.journalJournal of clinical medicine
dc.subject Graft-survıval
dc.subjectRecıpıents
dc.subjectOutcomes
dc.subjectGuıdelınes
dc.subjectDısease
dc.subjectAcute rejection
dc.subjectCadaveric transplantation
dc.subjectExpanded-criteria donors
dc.subjectMycophenolate mofetil
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectMedicine, General & Internal
dc.subjectGeneral & Internal Medicine
dc.titleUtility of deceased expanded-criteria donors in kidney transplantation: A single-center experience
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nefroloji Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication3b0ea0d7-f953-4c53-9e92-e260b04f90b4
relation.isAuthorOfPublicatione0f20ddb-a439-4c4a-b87e-d468370abf60
relation.isAuthorOfPublicationbd386ce4-0765-45b7-9a09-c10b5eca584a
relation.isAuthorOfPublication.latestForDiscovery3b0ea0d7-f953-4c53-9e92-e260b04f90b4

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Ersoy_vd_2025.pdf
Boyut:
1.62 MB
Format:
Adobe Portable Document Format